期刊文献+

Clinical impact and mechanisms of hepatitis B virus infection concurrent with non-alcoholic fatty liver disease 被引量:13

原文传递
导出
摘要 Chronic hepatitis B(CHB)virus infection is an important threat to global health despite the administration of vaccines and the use of antiviral treatments.In recent years,as the prevalence of obesity and metabolic syndrome has increased,non-alcoholic fatty liver disease(NAFLD)in patients with CHB has become more common.Both diseases can lead to liver fibrosis and even hepatocellular carcinoma,but the risk of dual etiology,outcome,and CHB combined with NAFLD is not fully elucidated.In this review,we assess the overlapping prevalence of NAFLD and CHB,summarize recent studies of clinical and basic research related to potential interactions,and evaluate the progressive changes of treatments for CHB patients with NAFLD.This review increases the understanding of the relationship and mechanisms of interaction between steatosis and hepatitis B virus infection,and it provides new strategies for the future clinical management and treatment of CHB combined with NAFLD.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2022年第14期1653-1663,共11页 中华医学杂志(英文版)
基金 supported by grants from the National Natural Science Fund(Nos.81970545,82170609) the Natural Science Foundation of Shandong Province(Major Project)(No.ZR2020KH006) the Ji’nan Science and Technology Development Project(No.202019079) the Nanjing Medical Science and Technique Development Foundation(No.YKK20058).
  • 相关文献

参考文献3

二级参考文献37

  • 1Kai SUN Qian WANG Xiao-hui HUANG.PPAR gamma inhibits growth of rat hepatic stellate cells and TGF beta-induced connective tissue growth factor expression[J].Acta Pharmacologica Sinica,2006,27(6):715-723. 被引量:35
  • 2Kamran Qureshi,Gary A Abrams.Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2007,13(26):3540-3553. 被引量:52
  • 3National Cholesterol Education Program Expert Panel.Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel Ⅲ). Journal of the American Medical Association, The . 2001
  • 4Frank B. Hu.Globalization of Diabetes The role of diet, lifestyle, and genes. Diabetes Care . 2011
  • 5Donna L. White,Fasiha Kanwal,Hashem B. El–Serag.Association Between Nonalcoholic Fatty Liver Disease and Risk for Hepatocellular Cancer, Based on Systematic Review[J].Clinical Gastroenterology and Hepatology.2012(12)
  • 6Jens Bukh.Animal Models for the Study of Hepatitis C Virus Infection and Related Liver Disease[J].Gastroenterology.2012(6)
  • 7Masahito Shimizu,Takuji Tanaka,Hisataka Moriwaki.Obesity and hepatocellular carcinoma: targeting obesity-related inflammation for chemoprevention of liver carcinogenesis[J].Seminars in Immunopathology.2013(2)
  • 8Paola Dongiovanni,Quentin M. Anstee,Luca Valenti.Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment[J].Current Pharmaceutical Design.2013(29)
  • 9ANGULO P.Nonalcoholic fatty liver disease[].The New England Journal of Medicine.2002
  • 10Fabio Nascimbeni,Raluca Pais,Stefano Bellentani,Christopher Paul Day,Vlad Ratziu,Paola Loria,Amedeo Lonardo.From NAFLD in clinical practice to answers from guidelines<!-- Doctopic: Review -->[J]. Journal of Hepatology . 2013

共引文献65

同被引文献61

引证文献13

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部